West Pharmaceutical Services sets up a manufacturing plant in the Sri City Special Economic Zone (SEZ), where the company will expand its growing primary packaging for injectable medicines business. It is understood that the company plans to expand its production at the site to include West's elastomer component business, in future.
In June 2012, West had signed a 99-year lease on 72,800 square meters of land in Sri City, which offers the advantages of a metropolitan location and was selected primarily on the suitability of land, availability of utilities, labor suitability, logistics and quality of life. Construction began in August 2012 on a 15,300 square meter facility that will produce seals used in primary packaging of injectable medicines manufactured by West's pharmaceutical and biopharmaceutical customers in India and the wider Asia Pacific region.
"West is experiencing a very exciting period of growth and business expansion in Asia and we are proud to open our first facility in India. With more and more pharmaceutical customers establishing operations in India, our new plant will help West meet market demand and further establish the company's presence in this growing and dynamic market,” said Donald E Morel, Junior, chairman and chief executive officer, West Pharmaceutical Services.
West's presence in the Asia Pacific market includes a plant in Singapore, two plants in Qingpu, China and sales offices in Australia, China, India and Singapore. West also owns 25 per cent of Japan based Daikyo Seiko, founded in 1954, a leader in the fields of pharmaceutical packaging and medical device components. The West-Daikyo relationship was formed in 1973 and includes joint marketing agreements and technology transfer and licensing agreements.